Assignee
ALNYLAM PHARMACEUTICALS
US·6 granted patents·3 pending applications·361 citations·filing 2004–2013
Top patents by PatentIndex Score
9 records- 0198US7723509B2IRNA agents with biocleavable tethersALNYLAM PHARMACEUTICALS·Filed 2004·Granted May 25, 2010·202 cites·41 claims
- 0296US9127274B2Serpinc1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS·Filed 2013·Granted Sep 8, 2015·51 cites·62 claims
- 0396US7626014B2Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moietyALNYLAM PHARMACEUTICALS·Filed 2005·Granted Dec 1, 2009·53 cites·64 claims
- 0494US7723512B2Oligonucleotides comprising a non-phosphate backbone linkageALNYLAM PHARMACEUTICALS·Filed 2009·Granted May 25, 2010·26 cites·10 claims
- 0590US7772387B2Oligonucleotides comprising a modified or non-natural nucleobaseALNYLAM PHARMACEUTICALS·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 0684US7674778B2Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidineALNYLAM PHARMACEUTICALS·Filed 2005·Granted Mar 9, 2010·7 cites·34 claims
- 0764US2010222417A1Compostions and methods for enhancing oligonucleotide delivery across and into epithelial tissuesALNYLAM PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 0851US2011065774A1Chemically modified oligonucleotides and uses thereofALNYLAM PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 0942US2010280102A1Double-stranded ribonucleic acid with increased effectiveness in an organismALNYLAM PHARMACEUTICALS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALNYLAM PHARMACEUTICALS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →